Abstract
Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with high lipoprotein (a) levels
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
